JPRN-UMIN000013091已完成未知
Oral medication using Tolvaptan for ADL of patients with acute congestive heart failure - Oral medication using Tolvaptan for ADL of patients with acute congestive heart failure
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •acute myocardial infarction severe respiratory failure (PaO2<60Torr, and/or SPO2<90% on oxygen administration) shock vital (sBP<90mmHg) serum sodium >146
研究者
相似试验
已完成
不适用
A study on effect of oral tolvaptan tablet, which causes free water excretion and increases serum sodium level, to prevent hyponatremia in patients undergoing TURP surgeries.CTRI/2019/04/018808Dr Badri Prasad Das84
已完成
不适用
The effect of Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist,after cardiac surgerypatients who receive off-pump coronary artery bypass surgeryJPRN-UMIN000011039Juntendo University Faculty of Medicine100
招募中
不适用
Efficasy and safety of tolvaptan in patients undergoing peritoneal dialysis with heart failure despite the standard treatment with conventionalJPRN-UMIN000008712Division of Kidney and Hypertension, the Jikei University School of Medicine40
已完成
4 期
Effects of low dose oral tolvaptan add on benefit in patients hospitalized for acute decompensated heart failure: A randomized controlled trialAcute decompensated heart failure is a common condition which increases morbidity and cardiovascular mortality. Most patients often suffer from dyspnea. The main treatments are to treat precipitating causes of AHF and to use diuretics for getting rid of water and salt from the body. Tolvaptan may improve these symptoms.TCTR20210316012/A40
尚未招募
不适用
A study of Tolvaptan to investigate the pharmacokinetics and diuretic effectcongestive heart failureJPRN-UMIN000006726Kanagawa Children's Medical Center10